Hunger and food insecurity don’t move in sync with oil prices—and right now, fertilizer supply and affordability remain a major global pressure point. Elizabeth Kennedy Trudeau from the George W. Bush Presidential Center explains the “long tail” of fertilizer disruptions and why the impact on farmers can extend well beyond the initial shock. We discuss […]

Nike’s turnaround is showing signs of progress, but not enough for Wall Street to call it a clean comeback. And this is a problem for investors. The athletic giant is still one of the strongest brands in the world, with a major global sports presence and powerful franchises across running, basketball, football, and lifestyle sneakers.

If you have been watching the monthly jobs numbers and wondering why they keep disappointing, Goldman Sachs may have part of your answer. June payrolls came in at just 57,000, less than half of what economists expected. April and May were revised down by a combined 74,000. And a growing number of economists are pointing

Tesla (TSLA) finally gave investors the number they had been waiting for. The electric-vehicle maker produced a lot more automobiles than Wall Street expected in the second quarter, giving bulls a much-needed data point following a tough stretch for CEO Elon Musk’s company. But the stock market did not rejoice for long. Tesla shares plunged

Eli Lilly (LLY) climbed to new record highs in the final week of June, driven by strong sales of its weight-loss drugs. Away from that spotlight, the drugmaker made changes to a smaller corner of its business in its second-largest market. On June 30, Lilly agreed to hand a Chinese partner full commercial control of

Costco, like many of its retail rivals, has embraced artificial intelligence (AI). That’s perhaps a little surprising given that the chain has traditionally waited for its rivals to prove the benefits of using emerging technology before adopting it. AI, while it has become common, has also had its fair share of missteps. Starbucks, for example,

TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Improving your health is one of the most popular trends of all time. You can take action by getting a gym membership, investing in a home

Wall Street just picked a new favorite in the AI chip race, and it isn’t the company most investors expect. According to Investing.com, Cantor Fitzgerald analyst C.J. Muse raised his price target on Advanced Micro Devices (AMD) to $700 from $500 on June 29, keeping his Overweight rating.  That makes it the highest AMD price

Guardant Health (GH) investors have a new number to think about this week.  Bernstein SocGen Group raised its price target on the cancer-screening company’s stock to $200 a share, up from $175. Bernstein also kept its Outperform rating intact. The new price target came less than a day after a major insurance decision boosted the

Nike’s stock clawed back most of a steep post-earnings drop this week. Days later, a convenience store chain filed a federal lawsuit trying to block one of Nike’s biggest sneaker launches of the summer. The two storylines are unfolding almost simultaneously, but they have nothing to do with each other. Shares fell as much as